LRH1 as a promising prognostic biomarker and predictor of metastasis in patients with non-small cell lung cancer.
Yuechao LiuYing XingHongmei WangShi YanXinzhu WangLi CaiPublished in: Thoracic cancer (2018)
The results of our study indicate that LRH1 predicts NSCLC progression, metastasis, and a dismal prognosis, emphasizing its promising role as a novel target in NSCLC therapies.